Podcast: How Fauna Bio Gleans Therapeutic Insights From Animals

In Vivo speaks with Ashley Zehnder, CEO of Fauna Bio, a company using AI to identify drug targets based on natural disease resistance in animals.

In Vivo Podcast

Ashley Zehnder, an exotic animal veterinarian and cancer biologist, co-founded Fauna Bio in 2018, after recognizing the potential to translate insights from non-human mammalian biology into human therapeutics.

The company’s AI platform, called Convergence, mines large datasets to identify genetic networks conserved across species that confer natural disease resistance

More from Podcasts

More from Innovation